title: Expressions of neuregulin 1beta and ErbB4 in prefrontal cortex and hippocampus of a rat schizophrenia model induced by chronic MK-801 administration.
abstract: Recent human genetic studies and postmortem brain examinations of schizophrenia patients strongly indicate that dysregulation of NRG1 and ErbB4 may be important pathogenic factors of schizophrenia. However, this hypothesis has not been validated and fully investigated in animal models of schizophrenia. In this study we quantitatively examined NRG1 and ErbB4 protein expressions by immunohistochemistry and Western blot in the brain of a rat schizophrenia model induced by chronic administration of MK-801 (a noncompetitive NMDA receptor antagonist). Our data showed that NRG1beta and ErbB4 expressions were significantly increased in the rat prefrontal cortex and hippocampus but in different subregions. These findings suggest that altered expressions of NRG1 and ErbB4 might be attributed to the schizophrenia. Further study in the role and mechanism of NRG1 and ErbB4 may lead to better understanding of the pathophysiology for this disorder.
authors.affiliation: Key Laboratory of Mental Health of National Health Ministry, Institute of Mental Health, Peking University, No. 51 Hua Yuan Bei Road, Haidian District, Beijing 100191, China.
authors.forename: Yu
authors.initials: Y
authors.lastname: Feng
authors.forename: Xiao-Dong
authors.initials: XD
authors.lastname: Wang
authors.forename: Chun-Mei
authors.initials: CM
authors.lastname: Guo
authors.forename: Yang
authors.initials: Y
authors.lastname: Yang
authors.forename: Ji-Tao
authors.initials: JT
authors.lastname: Li
authors.forename: Yun-Ai
authors.initials: YA
authors.lastname: Su
authors.forename: Tian-Mei
authors.initials: TM
authors.lastname: Si
mesh_terms: D000818:Animals; D015153:Blotting, Western; D004195:Disease Models, Animal; D016291:Dizocilpine Maleate / Q000009:adverse effects; D066246:ErbB Receptors / Q000378:metabolism*; D006624:Hippocampus / Q000378:metabolism*; D007150:Immunohistochemistry; D008297:Male; D020890:Neuregulin-1 / Q000378:metabolism*; D017397:Prefrontal Cortex / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D066247:Receptor, ErbB-4; D012559:Schizophrenia / Q000139:chemically induced / Q000378:metabolism
chemical_list: D020890:Neuregulin-1; C117467:neuregulin beta; D016291:Dizocilpine Maleate; C587689:ERBB4 protein, human; D066246:ErbB Receptors; C587691:Erbb4 protein, rat; D066247:Receptor, ErbB-4
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2006 Mar 5;141B(2):142-8
references.pmid: 16402353
references.citation: Brain Res. 1999 Oct 2;843(1-2):171-83
references.pmid: 10528123
references.citation: Annu Rev Neurosci. 2001;24:87-105
references.pmid: 11283306
references.citation: Annu Rev Neurosci. 1997;20:429-58
references.pmid: 9056721
references.citation: Hum Mol Genet. 2007 Jan 15;16(2):129-41
references.pmid: 17164265
references.citation: Behav Brain Res. 2004 Aug 12;153(1):159-70
references.pmid: 15219717
references.citation: Science. 2004 Apr 30;304(5671):700-3
references.pmid: 15044753
references.citation: Exp Cell Res. 2003 Mar 10;284(1):66-77
references.pmid: 12648466
references.citation: Biol Psychiatry. 2006 Apr 15;59(8):721-9
references.pmid: 16427029
references.citation: Am J Hum Genet. 2002 Oct;71(4):877-92
references.pmid: 12145742
references.citation: Nat Rev Neurosci. 2008 Jun;9(6):437-52
references.pmid: 18478032
references.citation: Neuron. 2000 May;26(2):443-55
references.pmid: 10839362
references.citation: Neuropsychopharmacology. 2006 Sep;31(9):1880-7
references.pmid: 16395297
references.citation: Schizophr Res. 2008 Mar;100(1-3):270-80
references.pmid: 18243664
references.citation: Nat Med. 2006 Jul;12(7):824-8
references.pmid: 16767099
references.citation: Int J Neuropsychopharmacol. 2008 Jun;11(4):553-61
references.pmid: 18184445
references.citation: Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3596-601
references.pmid: 10725395
references.citation: Curr Opin Neurobiol. 2006 Oct;16(5):492-500
references.pmid: 16962312
references.citation: Arch Gen Psychiatry. 1995 Dec;52(12):998-1007
references.pmid: 7492260
references.citation: Crit Rev Neurobiol. 2000;14(1):1-21
references.pmid: 11253953
references.citation: Neuron. 2005 Sep 1;47(5):681-94
references.pmid: 16129398
references.citation: Curr Opin Neurobiol. 2001 Jun;11(3):287-96
references.pmid: 11399426
references.citation: Brain Res Rev. 2006 Aug;51(2):161-75
references.pmid: 16412517
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2006 Jan 5;141B(1):96-101
references.pmid: 16249994
references.citation: Bioessays. 2000 Nov;22(11):987-96
references.pmid: 11056475
references.citation: Behav Brain Res. 2000 May;109(2):219-27
references.pmid: 10762692
references.citation: Neuropsychopharmacology. 1999 Mar;20(3):201-25
references.pmid: 10063482
references.citation: Prog Brain Res. 2005;147:319-45
references.pmid: 15581715
references.citation: Lancet. 2003 Feb 1;361(9355):417-9
references.pmid: 12573388
references.citation: J Neurosci Methods. 2006 Jan 30;150(2):159-73
references.pmid: 16085318
references.citation: Mol Psychiatry. 2005 Jan;10(1):40-68; image 5
references.pmid: 15263907
references.citation: J Neuropsychiatry Clin Neurosci. 1994 Fall;6(4):419-27
references.pmid: 7841813
references.citation: Neuropsychopharmacology. 2010 Jan;35(1):258-77
references.pmid: 19693005
references.citation: Int J Neuropsychopharmacol. 2007 Jun;10(3):359-68
references.pmid: 16780607